Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: Biodistribution and metabolism

Bioconjugate Chemistry

Volumn 7, Issue 4, 1996, Pages 511-522

  Rogers, Buck E ^a,d   Anderson, Carolyn J ^a   Connett, Judith M ^b   Guo, Li Wu ^b   Edwards, W Barry ^a   Sherman, Elizabeth L C ^a   Zinn, Kurt R ^c,d   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; CHELATION; COPPER; MONOCLONAL ANTIBODIES; PHYSIOLOGY; RADIOISOTOPES; RATS; TOXICITY; TUMORS;

BIFUNCTIONAL CHELATING AGENT; BIODISTRIBUTIONS; IN-VIVO; METHYL BENZOIC ACID; POST INJECTION; RADIOLABELLING; SIZE-EXCLUSION CHROMATOGRAPHY; TETRAACETIC ACID; THIN-LAYER CHROMATOGRAPHY; TRANSCHELATION;

METABOLISM;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030198251     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9600372     Document Type: Article

References (61)

1. Keenan, A. M., Harbert, J. C., and Larson, S. M. (1985) Monoclonal Antibodies in Nuclear Medicine. J. Nucl. Med. 26, 531-537.
2. Waldmann, T. A. (1991) Monoclonal Antibodies in Diagnosis and Therapy. Science 252, 1657-1662.
3. DeNardo, S., DeNardo, G., Kukis, D., Mausner, L., Moody, D., and Meares, C. (1991) Pharmacology of Cu-67-TETA-Lym-1 Antibody in Patients with B Cell Lymphoma. Antibody, Immunoconjugates, Radiopharm. 4, 36.
4. DeNardo, G. L., DeNardo, S. J., Meares, C. F., Salako, Q., Kukis, D. L., Mausner, L. F., Lewis, J. P., O'Grady, L. F., and Srivastava, S. C. (1993) Pilot Therapy of Lymphoma with Fractionated Cu-67-BAT-Lym-1. J. Nucl. Med. 34, 93P.
5. Delaloye, A. B., Buchegger, F., Smith, A., Schubiger, P. A., Maecke, H. R., Poncioni, L., Gillet, M., Mach, J. P., and Delaloye, B. (1994) Cu-67-Anti-CEA MAb, A Potential Therapeutic Agent: Biokinetic Studies in Patients with Colon Carcinoma. J. Nucl. Med. 35, 101P.
6. Philpott, G. W., Dehdashti, F., Schwarz, S. W., Connett, J. M., Anderson, C. J., Zinn, K. R., Meares, C. F., Welch, M. J., and Siegel, B. A. (1994) Positron Emission Tomography (PET) with Cu-64-Labeled Monoclonal Antibody (MAb 1A3) in Colorectal Cancer. J. Nucl. Med. 35, 12P.
7. Philpott, G. W., Dehdashti, F., Schwarz, S. W., Connett, J. M., Anderson, C. J., Zinn, K. R., Cutler, P. D., Welch, M. J., and Siegel, B. A. (1995) RadioimmunoPET (MAb-PET) with Cu-64-Labeled Monoclonal Antibody (MAb 1A3) Fragments [F(ab′)2] in Patients with Colorectal Cancers. J. Nucl. Med. 36, 9P.
8. Philpott, G. W., Schwarz, S. W., Anderson, C. J., Dehdashti, F., Connett, J. M., Zinn, K. R., Meares, C. F., Cutler, P. D., Welch, M. J., and Siegel, B. A. (1995) RadioimmunoPET: Detection of Colorectal Carcinoma with Positron-Emitting Copper-64-Labeled Monoclonal Antibody. J. Nucl. Med. 36, 1818-1824.
9. Apelgot, S., Coppey, J., Gaudemer, A., Grisvard, J., Guille, E., Sasaki, I., and Sissoeff, I. (1989) Similar Lethal Effect in Mammalian Cells for Two Radioisotopes of Copper with Different Decay Schemes, Cu-64 and Cu-67. Int. J. Radiat. Biol. 55, 365-384.
10. Connett, J. M., Anderson, C. J., Baumann, M. L., Schwarz, S. W., Zinn, K. R., Philpott, G. W., and Welch, M. J. (1993) Cu-67 and Cu-64 labeled monoclonal antibody (MAb) as potential agents for radioimmunotherapy. J. Nucl. Med. 34, 216P.
11. Anderson, C. J., Connett, J. M., Guo, L. W., Schwarz, S. W., Philpott, G. W., Zinn, K. R., and Welch, M. J. (1994) Initial comparison of Cu-67 and Cu-64-labeled anticolorectal carcinoma MAb 1A3 as agents for radioimmunotherapy in tumor-bearing hamsters. J. Nucl. Med. 35, 161P.
12. Deshpande, S. V., Subramanian, R., McCall, M. J., DeNardo, S. J., DeNardo, G. L., and Meares, C. F. (1990) Metabolism of Indium Chelates Attached to Monoclonal Antibody: Minimal Transchelation of Indium from Benzyl-EDTA Chelate In Vivo. J. Nucl. Med. 31, 218-224.
13. Deshpande, S. V., DeNardo, S. J., Kukis, D. L., Moi, M. K., McCall, M. J., DeNardo, G. L., and Meares, C. F. (1990) Yttrium-90-Labeled Monoclonal Antibody for Therapy: Labeling by a New Macrocyclic Bifunctional Chelating Agent. J. Nucl. Med. 31, 473-479.
14. DeNardo, G. L., Kroger, L. A., DeNardo, S. J., Miers, L. A., Salako, Q., Kukis, D. L., Fand, I., Shen, S., Renn, O., and Meares, C. F. (1994) Comparative Toxicity Studies of Yttrium-90 MX-DTPA and 2-IT-BAD Conjugated Monoclonal Antibody (BrE-3). Cancer 73, 1012-1022.
15. Anderson, C. J., Rogers, B. E., Connett, J. M., Guo, L. W., Schwarz, S. W., Zinn, K. R., and Welch, M. J. (1994) Comparison of Two Bifunctional Chelates for Labeling Cu64 to MAb 1A3 and 1A3-F(ab′)2: Chemistry and Animal Biodistribution. J. Labelled Compd Radiopharm. 35, 313-315.
16. Anderson, C. J., Connett, J. M., Schwarz, S. W., Rocque, P. A., Guo, L. W., Philpott, G. W., Zinn, K. R., Meares, C. F., and Welch, M. J. (1992) Copper-64-Labeled Antibodies for PET Imaging. J. Nucl. Med. 33, 1685-1691.
17. Anderson, C. J., Schwarz, S. W., Connett, J. M., Cutler, P. D., Guo, L. W., Germain, C. J., Philpott, G. W., Zinn, K. R., Greiner, D. P., Meares, C. F., and Welch, M. J. (1995) Preparation, Biodistribution, and Dosimetry of Copper-64-Labeled Anti-Colorectal Carcinoma Monoclonal Antibody Fragments 1A3-F(ab′)2. J. Nucl. Med. 36, 850-858.
18. Subramanian, R., and Meares, C. F. (1990) Bifunctional chelating agents for radiometal-labeled monoclonal antibodies. Cancer Imaging with Radiolabeled Antibodies (D. M. Goldenberg, Ed.) pp 183-199, Kluwer Academic Publishers, New York.
19. McCall, M. J., Diril, H., and Meares, C. F. (1990) Simplified Method for Conjugating Macrocyclic Bifunctional Chelating Agents to Antibodies via 2-Iminothiolane. Bioconjugate Chem. 1, 222-226.
20. Smith-Jones, P. M., Fridrich, R., Kaden, T. A., Novak-Hofer, I., Siebold, K., Tschudin, D., and Maecke, H. R. (1991) Antibody Labeling with Copper-67 Using the Bifunctional Macrocycle 4-[(1,4,8,11-Tetraazacyclotetradec-1-yl)methyl]-benzoic Acid. Bioconjugate Chem. 2, 415-421.
21. Motekaitis, R. J., Rogers, B. E., Reichert, D. E., Martell, A. E., and Welch, M. J. (1996) Stability and Structure of Activated Macrocycles. Ligands with Biological Applications. Inorg. Chem., in press.
22. Clarke, E. T., and Martell, A. E. (1991) Stabilities of the alkaline earth and divalent transition metal complexes of the tetraazamacrocyclic tetraacetic acid ligands. Inorg. Chim. Acta 190, 27-36.
23. Motta-Hennessy, C., Sharkey, R. M., and Goldenberg, D. M. (1990) Metabolism of Indium-111-Labeled Murine Monoclonal Antibody in Tumor and Normal Tissue of the Athymic Mouse. J. Nucl. Med. 31, 1510-1519.
24. 111In-labeled Monoclonal Antibody B6.2 by the Rat Liver. Cancer Res. 50, 852s-856s.
25. Sands, H., and Jones, P. L. (1987) Methods for the Study of the Metabolism of Radiolabeled Monoclonal Antibodies by Liver and Tumor. J. Nucl. Med. 28, 390-398.
26. Paik, C. H., Sood, V. K., Le, N., Cioloca, L., Carrasquillo, J. A., Reynolds, J. C., Neumann, R. D., and Reba, R. C. (1992) Radiolabeled Products in Rat Liver and Serum after Administration of Antibody-Amide-DTPA-Indium-111. Nucl. Med. Biol. 19, 517-522.
27. 111In-labeled Antibodies. Int. J. Radiat. Appl. Instrum., Part B 16, 839-845.
28. Duncan, J. R., and Welch, M. J. (1993) Intracellular Metabolism of Indium-111-DTPA Labeled Receptor Targeted Proteins. J. Nucl. Med. 34, 1728-1738.
29. 111In-DTPA-∈-lysine as the Primary Metabolic and Excretory Product. Nucl. Med. Biol. 21, 1023-1034.
30. Rogers, B. E., Franano, F. N., Duncan, J. R., Edwards, W. B., Anderson, C. J., Connett, J. M., and Welch, M. J. (1995) Identification of Metabolites of In-111-DTPA-Monoclonal Antibodies and Antibody Fragments In Vivo. Cancer Res. 55, 5714s-5720s.
31. Zinn, K. R., Chaudhuri, T. R., Cheng, T. P., Morris, J. S., and Meyer, W. A. (1994) Production of No-Carrier-Added Cu-64 from Zinc Metal Irradiated under Boron Shielding. Cancer 73, 774-778.
32. Moi, M. K., Meares, C. F., McCall, M. J., Cole, W. C., and DeNardo, S. J. (1985) Copper Chelates as Probes of Biological Systems: Stable Copper Complexes with a Macrocyclic Bifunctional Chelating Agent. Anal. Biochem. 148, 249-253.
33. Moran, J. K., Greiner, D. P., and Meares, C. F. (1995) Improved Synthesis of 6-[p-(Bromoacetamido)benzyl]-1,4,8,-11-tetraazacyclotetradecane-N,N′, N″,N‴-tetraacetic Acid and Development of a Thin-Layer Assay for Thiol-Reactive Bifunctional Chelating Agents. Bioconj. Chem. 6, 296-301.
34. McMurry, T. J., Brechbiel, M., Kumar, K., and Gansow, O. A. (1992) Convenient Synthesis of Bifunctional Tetraaza Macrocycles. Bioconjugate Chem. 3, 108-117.
35. Studer, M., and Kaden, T. A. (1986) One-Step Synthesis of Mono-N-substituted Azamacrocycles with a Carboxylic Group in the Side-Chain and their Complexes with Cu2+ and Ni2+. Helv. Chim. Acta 69, 2081-2086.
36. Folch, J. R., Lees, M., and Sloane-Stanley, G. H. (1957) Simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509.
37. Goldenberg, D. M., Witte, S., and Elster, K. (1966) GW-39: A New Human Tumor Serially Transplantable in the Golden Hamster. Transplantation 4, 760-763.
38. Rogers, B. E. (1995) Synthesis and Investigation of Bifunctional Chelating Agents for Radiolabeling Monoclonal Antibodies. Ph.D. Thesis, Washington University.
39. Rana, T. M., and Meares, C. F. (1990) N-Terminal Modification of Immunoglobulin Polypeptide Chains Tagged with Isothiocyanato Chelates. Bioconjugate Chem. 1, 357-362.
40. Means, G. E., and Feeney, R. E. (1971) Chemical Modification of Proteins, pp 11-17, Holden-Day, Inc., San Francisco, CA.
41. Owen, C. A. (1982) Biochemical Aspects of Copper: Copper Proteins, Ceruloplasmin, and Copper Protein Binding, Noyes Publications, New Jersey.
42. Winge, D. R. (1984) Normal Physiology of Copper Metabolism. Semin. Liver Dis. 4, 239-251.
43. Van Hein, P., Kovacs, K., and Matkovics, B. (1975) Properties of Enzymes II. Comparative study of superoxide dismutase activity in rat tissues. Enzyme 19, 1-4.
44. Meares, C. F., McCall, M. J., Deshpande, S. V., DeNardo, S. J., and Goodwin, D. A. (1988) Chelate Radiochemistry: Cleavable Linkers Lead to Altered Levels of Radioactivity in the Liver. Int. J. Cancer 2, 99-102.
45. Arano, Y., Mukai, T., Uezono, T., Wakisaka, K., Motonari, H., Akizawa, H., Taoka, Y., and Yokoyama, A. (1994) A Biological Method to Evaluate Bifunctional Chelating Agents to Label Antibodies with Metallic Radionuclides. J. Nucl. Med. 35, 890-898.
46. Arano, Y., Mukai, T., Akizawa, H., Uezono, T., Motonari, H., Wakisaka, K., Kairiyama, C., and Yokoyama, A. (1995) Radiolabeled Metabolites of Proteins Play a Critical Role in Radioactivity Elimination from the Liver. Nucl. Med. Biol. 22, 555-564.
47. Anderson, C. J., Pajeau, T. S., Edwards, W. B., Sherman, E. L. C., Rogers, B. E., and Welch, M. J. (1995) In vitro and in vivo Evaluation of Copper-64-Labeled Octreotide Conjugates. J. Nucl. Med. 36, 2315-2325.
48. Jones-Wilson, T. M. (1995) Preparation and Evaluation of Potential Radiopharmaceuticals labeled with gallium-67,68, indium-111, and Cu-64,67: Relationships between structure and biological activity. Ph.D. Thesis, Washington University.
49. Hansch, C., and Leo, A. (1979) Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley-Interscience Publication, New York.
50. Maack, T., and Park, C. H. (1990) Endocytosis and lysosomal hydrolysis of proteins in proximal tubules. Methods Enzymol. 191, 340-354.
51. Martell, A. E., and Smith, R. M. (1982) Critical Stability Constants, Plenum Press, New York.
52. Kukis, D. L., Li, M., and Meares, C. F. (1993) Selectivity of Antibody-Chelate Conjugates for Binding Copper in the Presence of Competing Metals. Inorg. Chem. 32, 3981-3982.
53. Maack, T., Park, C. H., and Camargo, J. F. (1992) Renal Filtration, Transport, and Metabolism of Proteins. The Kidney: Physiology and Pathophysiology (D. W. Seldin and G. Giebisch, Eds.) pp 3005-3038, Raven Press, Ltd., New York.
54. Yokota, T., Milenic, D. E., Whitlow, M., Wood, J. F., Hubert, S. L., and Schlom, J. (1993) Microautoradiographic Analysis of the Normal Organ Distribution of Radioiodinated Single-Chain Fv and Other Immunoglobulin Forms. Cancer Res. 53, 3776-3783.
55. Fischman, A. J., Pike, M. C., Kroon, D., Fucello, A. J., Rexinger, D., tenKate, C., Wilkinson, R., Rubin, R. H., and Strauss, H. W. (1991) Imaging Focal Sites of Bacterial Infection in Rats with Indium-111-Labeled Chemotactic Peptide Analogs. J. Nucl. Med. 32, 483-491.
56. Bakker, W. H., Krenning, E. P., Reubi, J. C., Breeman, W. A. P., Setyono-Han, B., de Jong, M., Kooij, P. P. M., Bruns, C., van Hagen, P. M., Marbach, P., Visser, T. J., Pless, J., and Lamberts, S. W. J. (1991) In Vivo Application of [In-111-DTPA-D-Phe]-Octreotide for Detection of Somatostatin Receptor-Positive Tumors in Rats. Life Sci. 49, 1593-1601.
57. Geissler, F., Anderson, S. K., and Press, O. (1991) Intracellular Catabolism of Radiolabeled Anti-CD3 Antibodies by Leukemic T Cells. Cell. Immunol. 137, 96-110.
58. Scharschmidt, B. F., Lake, J. R., Renner, E. L., Licko, V., and Van Dyke, R. W. (1986) Fluid phase endocytosis by cultured rat hepatocytes and perfused rat liver: Implications for plasma membrane turnover and vesicular trafficking of fluid phase markers. Proc. Natl. Acad. Sci. U.S.A. 83, 9488-9492.
59. Yamazaki, K., and LaRusso, N. F. (1989) The Liver and Intracellular Digestion: How Liver Cells Eat! Hepatology 10, 877-886.
60. Straus, W. (1964) Cytochemical observations on the relationship between lysosomes and phagosomes in the kidney and liver by combined staining for acid phosphatase and intravenously injected horseradish peroxidase. J. Cell Biol. 497-507.
61. Schneider, Y.-J., Tulkens, P., de Duve, C., and Trouet, A. (1979) Fate of plasma membrane during endocytosis II. Evidence for recycling (shuttle) of plasma membrane constituents. J. Cell Biol. 82, 466-474.